HOME
|
WORLDWIDE
|
SITE MAP
|
FRANÇAIS
Font size
Smaller Font
Regular Font
Large Font
Search
Print
Email
History/Brand Mark
Business Philosophy
Corporate Culture
Astellas News
Company Facts
Press Releases
Contact Us
Feedback
Product Portfolio
Immunology
Anti-infectives
Dermatology
Cardiology
Urology
Oncology
Research & Development
Job Opportunities
Apply Online
Social Contributions
Eczema Support
Psoriasis Support
Transplant Support
Overactive Bladder Support
Community Support
Astellas Aspire
Astellas News
Home
>
About Astellas
> Astellas News
History/Brand Mark
Business Philosophy
(Mission Statement, Raison d'être)
Corporate Culture
Astellas News
Company Facts
Press Releases
Contact Us
Feedback
Latest News
Canadian Urological Association Partners with Astellas Pharma Canada, Inc.
March 28, 2012
Young eczema sufferer wishes her disease away through art - and wins!
March 16, 2012
Medivation and Astellas Announce Positive Results from the Phase 3 AFFIRM Trial of MDV3100 in Prostate Cancer Patients Who Received Prior Chemotherapy
February 1, 2012
Astellas announces new Vice President of Sales and Marketing
January 26, 2012
Astellas and Theravance Announce Termination of License, Development and Commercialization Agreement for VIBATIV® (telavancin) for Injection
January 10, 2012
The Eczema Society of Canada and EASE invite kids to express disease through art
November 1, 2011
Site Map
|
Privacy Policy
|
Legal Disclaimer
|
Contact Us
© 2011 Astellas Pharma Canada, Inc. All Rights Reserved.